HK1205460A1 - Long-acting coagulation factors and methods of producing same - Google Patents

Long-acting coagulation factors and methods of producing same

Info

Publication number
HK1205460A1
HK1205460A1 HK15106044.6A HK15106044A HK1205460A1 HK 1205460 A1 HK1205460 A1 HK 1205460A1 HK 15106044 A HK15106044 A HK 15106044A HK 1205460 A1 HK1205460 A1 HK 1205460A1
Authority
HK
Hong Kong
Prior art keywords
methods
long
coagulation factors
producing same
acting coagulation
Prior art date
Application number
HK15106044.6A
Other languages
English (en)
Chinese (zh)
Inventor
Udi Eyal Fima
Gili Hart
Original Assignee
Opko Biolog Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48983616&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1205460(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/372,540 external-priority patent/US8759292B2/en
Application filed by Opko Biolog Ltd filed Critical Opko Biolog Ltd
Publication of HK1205460A1 publication Critical patent/HK1205460A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
HK15106044.6A 2012-02-14 2015-06-25 Long-acting coagulation factors and methods of producing same HK1205460A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/372,540 US8759292B2 (en) 2006-02-03 2012-02-14 Long-acting coagulation factors and methods of producing same
PCT/IL2013/050107 WO2013121416A1 (en) 2012-02-14 2013-02-05 Long-acting coagulation factors and methods of producing same

Publications (1)

Publication Number Publication Date
HK1205460A1 true HK1205460A1 (en) 2015-12-18

Family

ID=48983616

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106044.6A HK1205460A1 (en) 2012-02-14 2015-06-25 Long-acting coagulation factors and methods of producing same

Country Status (22)

Country Link
EP (3) EP3326642B1 (xx)
JP (2) JP6242819B2 (xx)
KR (3) KR102630953B1 (xx)
CN (2) CN109535245A (xx)
AU (3) AU2013219935B2 (xx)
BR (1) BR122021004014B1 (xx)
CA (1) CA2870621C (xx)
CL (2) CL2014002183A1 (xx)
CO (1) CO7131365A2 (xx)
DK (2) DK2822576T3 (xx)
EA (2) EA028578B1 (xx)
ES (2) ES2665319T3 (xx)
HK (1) HK1205460A1 (xx)
HU (1) HUE053068T2 (xx)
IL (2) IL264959B (xx)
MX (3) MX362446B (xx)
MY (1) MY172539A (xx)
NO (1) NO2920022T3 (xx)
PE (1) PE20142290A1 (xx)
PL (1) PL3326642T3 (xx)
SG (1) SG11201404836QA (xx)
WO (1) WO2013121416A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
ES2665319T3 (es) * 2012-02-14 2018-04-25 Opko Biologics Ltd. Factores de coagulación de acción prolongada y métodos para producir los mismos
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
TW202231657A (zh) * 2014-12-10 2022-08-16 以色列商歐科生物製品有限公司 製造長效ctp修飾的多肽之方法
EP3988113A1 (en) * 2015-06-19 2022-04-27 OPKO Biologics Ltd. Long-acting coagulation factors and methods of producing same
TWI741992B (zh) 2015-08-03 2021-10-11 美商百歐維拉提夫治療公司 因子ｉｘ融合蛋白以及其製備及使用方法
EP4303228A3 (en) * 2016-07-11 2024-03-13 OPKO Biologics Ltd. Long-acting coagulation factor vii and methods of producing same
CN106279437B (zh) 2016-08-19 2017-10-31 安源医药科技（上海）有限公司 高糖基化人凝血因子viii融合蛋白及其制备方法与用途
EP3502143A4 (en) 2016-08-19 2020-07-15 Ampsource Biopharma Shanghai Inc. BINDING PEPTIDE FOR THE CONSTRUCTION OF A FUSION PROTEIN
CN107759696A (zh) 2016-08-19 2018-03-06 安源医药科技（上海）有限公司 人白介素7融合蛋白及其制备方法
JP7023925B2 (ja) 2017-03-08 2022-02-22 テイ・エス テック株式会社 乗物用シート

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
DE3421468A1 (de) 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
JP2874751B2 (ja) 1986-04-09 1999-03-24 ジェンザイム・コーポレーション 希望する蛋白質をミルク中へ分泌する遺伝子移植動物
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US6225449B1 (en) 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
ES2098261T3 (es) 1989-02-21 1997-05-01 Univ Washington Formas modificadas de hormonas reproductoras.
US5792460A (en) * 1989-02-21 1998-08-11 Washington University Modified glycoprotein hormones having a CTP at the amino terminus
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US7795210B2 (en) * 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
CN1245510C (zh) * 2003-09-25 2006-03-15 复旦大学 长效重组组织因子途径抑制物及其制备方法
US8476234B2 (en) * 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
WO2007092252A2 (en) 2006-02-03 2007-08-16 Modigene Inc Long-acting polypeptides and methods of producing same
US8759292B2 (en) * 2006-02-03 2014-06-24 Prolor Biotech, Llc Long-acting coagulation factors and methods of producing same
US8048849B2 (en) * 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
TWI465247B (zh) * 2008-04-11 2014-12-21 Catalyst Biosciences Inc 經修飾的因子ｖｉｉ多肽和其用途
RU2526804C2 (ru) * 2008-08-06 2014-08-27 Ново Нордиск Хелс Кеа Аг Конъюгированные белки с пролонгированным действием in vivo
ES2665319T3 (es) 2012-02-14 2018-04-25 Opko Biologics Ltd. Factores de coagulación de acción prolongada y métodos para producir los mismos
BR122020018510B1 (pt) * 2012-11-20 2023-03-14 Opko Biologics Ltd Método para aumentar incrementalmente o tamanho hidrodinâmico de um fator de coagulação ativado viia

Also Published As

Publication number Publication date
JP2018065815A (ja) 2018-04-26
JP2015508771A (ja) 2015-03-23
EP3326642A1 (en) 2018-05-30
KR20210125595A (ko) 2021-10-18
EP2822576A4 (en) 2015-11-25
KR20200063274A (ko) 2020-06-04
CO7131365A2 (es) 2014-12-01
CL2014002183A1 (es) 2015-01-09
DK2822576T3 (en) 2018-04-16
KR102310704B1 (ko) 2021-10-08
EA028578B1 (ru) 2017-12-29
KR102630953B1 (ko) 2024-01-29
PL3326642T3 (pl) 2021-06-14
EP3326642B1 (en) 2020-11-25
AU2016202829B2 (en) 2017-05-25
IL282121A (en) 2021-05-31
CA2870621A1 (en) 2013-08-22
CA2870621C (en) 2022-08-09
BR112014020198A2 (pt) 2018-05-15
MX2022008807A (es) 2022-08-11
ES2855133T3 (es) 2021-09-23
DK3326642T3 (da) 2021-02-22
AU2016202829A1 (en) 2016-05-19
JP6242819B2 (ja) 2017-12-06
EA201491519A1 (ru) 2014-12-30
BR122021004014B1 (pt) 2022-12-27
MX2019000708A (es) 2020-09-02
ES2665319T3 (es) 2018-04-25
KR20140134673A (ko) 2014-11-24
CN104427994A (zh) 2015-03-18
MY172539A (en) 2019-11-30
HUE053068T2 (hu) 2021-06-28
AU2013219935B2 (en) 2016-02-04
AU2017219044B2 (en) 2019-05-30
EA201790960A3 (ru) 2018-01-31
IL264959B (en) 2021-08-31
EP3791890A1 (en) 2021-03-17
PE20142290A1 (es) 2015-01-15
EP2822576B1 (en) 2018-01-10
JP6510002B2 (ja) 2019-05-08
WO2013121416A1 (en) 2013-08-22
IL282121B (en) 2022-06-01
MX2014009910A (es) 2015-09-28
NO2920022T3 (xx) 2018-06-09
CL2017002233A1 (es) 2018-05-11
AU2017219044A1 (en) 2017-09-14
CN109535245A (zh) 2019-03-29
AU2013219935A1 (en) 2014-09-25
MX362446B (es) 2019-01-18
EA201790960A2 (ru) 2017-09-29
KR102118729B1 (ko) 2020-06-05
EP2822576A1 (en) 2015-01-14
SG11201404836QA (en) 2014-12-30

Similar Documents

Publication Publication Date Title
IL282121B (en) Long-term coagulation factors and methods for their preparation
HK1207564A1 (en) Long-acting oxyntomodulin variants and methods of producing same
IL239353B (en) Continuous production unit and methods for using it
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
GB201223276D0 (en) Antibodies and methods of producing same
EP2844903A4 (en) TUBES AND METHOD FOR THE PRODUCTION AND USE THEREOF
SG11201400246SA (en) Hyperbranched polymers and methods of making and using same
EP2866854A4 (en) METHODS OF USING POLYMERS
EP2844364A4 (en) SEALED SEAM FILTER AND METHOD OF MANUFACTURING THEREOF
EP2919983A4 (en) ARTICLES WITH FIBER-REINFORCED POLYMERS AND METHOD OF USE THEREOF
HK1214958A1 (zh) 凝血酶溶液及其使用方法
PL2931937T3 (pl) Sposób wytwarzania układów nanocząstek metali
HK1176820A1 (en) Method of preparing soymilk
HK1204473A1 (en) Methods of making and using nanostructures
GB201220155D0 (en) Method of manufacture
IL237862A0 (en) Methods to reduce the formation of scale
EP2670245A4 (en) ALPHA-CÉTOHÉTÉROCYCLES AND METHODS OF MAKING AND USING THEM
GB2509246B (en) Component and method of formation thereof
EP2925341A4 (en) PEPTIDE COMPOUNDS AND METHODS OF MAKING AND USING THEM
PL2807212T3 (pl) Pianki z polimerów ligniny i pochodnej furanu oraz sposób ich wytwarzania
EP2864417A4 (en) POLYMER AND METHOD OF USE
GB201316230D0 (en) Catalysts and methods of making and using catalysts
IL234082A0 (en) Long-term coagulation factors and methods for their preparation
EP2887938A4 (en) PROCESS FOR PREPARING TECOVIRIMAT